About: Alverine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alverine Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/drugbank/Drug, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	http://linked.opendata.cz/ontology/drugbank/Drug
http://linked.open...gbank/description	Alverine is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasms which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. It is used to relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine is formulated as the citrate salt (5982-87-6). (en)
http://linked.open...generalReferences	# Hayase M, Hashitani H, Suzuki H, Kohri K, Brading AF: Evolving mechanisms of action of alverine citrate on phasic smooth muscles. Br J Pharmacol. 2007 Dec;152(8):1228-38. Epub 2007 Oct 15. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17934514 # Wittmann T, Paradowski L, Ducrotte P, Bueno L, Andro Delestrain MC: Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2010 Mar;31(6):615-24. Epub 2009 Dec 10. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/20003095 # Ju D, Wang X, Xie Y: Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells. Int J Mol Med. 2009 Feb;23(2):205-9. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/19148544 # "Spasmonal Package Insert":http://www.medicines.org.uk/EMC/medicine/24562/SPC/ (en)
http://linked.open...gy/drugbank/group	approved (en)
http://linked.open...drugbank/halfLife	The plasma half-life averages 0.8 hours for alverine and 5.7 hours for the active primary metabolite. (en)
http://linked.open...ugbank/indication	Used to relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine citrate is also under investigation to increase the cytotoxic effects of the proteasome inhibitor MG132 on breast cancer cells. (en)
sameAs	Alverine
Title	Alverine (en)
adms:identifier	http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/chebi/518413 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/chemspider/3550 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/drugbank/DB01616 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/kegg-drug/D07440 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/pubchem-compound/3678 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/pubchem-substance/46506981 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/pharmgkb/PA164764505 http://linked.opendata.cz/resource/drugbank/drug/DB01616/identifier/wikipedia/Alverine
http://linked.open...outeOfElimination	High renal clearance of all metabolites indicating that they are eliminated by active renal secretion. (en)
http://linked.open.../drugbank/synonym	Bis(gamma-phenylpropyl)ethylamine (en) Di(phenylpropyl)ethylamine (en) N,N-Bis(3-phenylpropyl)ethylamine (en) N-Ethyl-3,3'-diphenyldipropylamine (en) N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine (en) N-Ethyl-N-(3-phenylpropyl)benzenepropanamine (en) Phenopropamine (en) Phenpropamine (en) Alverina (en) Alverinum (en)
http://linked.open...drugbank/toxicity	Can produce hypotension and atropine-like toxic effects. Fatality has occurred following overdose with very high doses. (en)
http://linked.open...ogy/drugbank/salt	(en)
http://linked.open...ugbank/IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B5C98-363D-11E5-9242-09173F13E4C5
http://linked.open...gy/drugbank/InChI	http://linked.opendata.cz/resource/drugbank/property/271B5C9E-363D-11E5-9242-09173F13E4C5
http://linked.open...Molecular-Formula	http://linked.opendata.cz/resource/drugbank/property/271B5C9D-363D-11E5-9242-09173F13E4C5
http://linked.open.../Molecular-Weight	http://linked.opendata.cz/resource/drugbank/property/271B5C9A-363D-11E5-9242-09173F13E4C5
http://linked.open...noisotopic-Weight	http://linked.opendata.cz/resource/drugbank/property/271B5C9B-363D-11E5-9242-09173F13E4C5
http://linked.open...y/drugbank/SMILES	http://linked.opendata.cz/resource/drugbank/property/271B5C9C-363D-11E5-9242-09173F13E4C5
http://linked.open.../Water-Solubility	http://linked.opendata.cz/resource/drugbank/property/271B5C96-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logP	http://linked.opendata.cz/resource/drugbank/property/271B5C94-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B5C97-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logS	http://linked.opendata.cz/resource/drugbank/property/271B5C95-363D-11E5-9242-09173F13E4C5
http://linked.open...l/drug/hasATCCode	Alverine
http://linked.open...nd-Acceptor-Count	http://linked.opendata.cz/resource/drugbank/property/271B5CA4-363D-11E5-9242-09173F13E4C5
http://linked.open...-Bond-Donor-Count	http://linked.opendata.cz/resource/drugbank/property/271B5CA5-363D-11E5-9242-09173F13E4C5
http://linked.open...drugbank/InChIKey	http://linked.opendata.cz/resource/drugbank/property/271B5C9F-363D-11E5-9242-09173F13E4C5
http://linked.open...urface-Area--PSA-	http://linked.opendata.cz/resource/drugbank/property/271B5CA0-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/Polarizability	http://linked.opendata.cz/resource/drugbank/property/271B5CA2-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Refractivity	http://linked.opendata.cz/resource/drugbank/property/271B5CA1-363D-11E5-9242-09173F13E4C5
http://linked.open...atable-Bond-Count	http://linked.opendata.cz/resource/drugbank/property/271B5CA3-363D-11E5-9242-09173F13E4C5
http://linked.open.../affectedOrganism	Humans and other mammals (en)
http://linked.open...casRegistryNumber	150-59-4 (en)
http://linked.open...drugbank/category	(en)
http://linked.open...k/Bioavailability	http://linked.opendata.cz/resource/drugbank/property/271B5CA9-363D-11E5-9242-09173F13E4C5
http://linked.open...ank/Boiling-Point	http://linked.opendata.cz/resource/drugbank/property/271B5CAE-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Ghose-Filter	http://linked.opendata.cz/resource/drugbank/property/271B5CAB-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/MDDR-Like-Rule	http://linked.opendata.cz/resource/drugbank/property/271B5CAC-363D-11E5-9242-09173F13E4C5
http://linked.open...ank/Melting-Point	http://linked.opendata.cz/resource/drugbank/property/271B5CAD-363D-11E5-9242-09173F13E4C5
http://linked.open...k/Number-of-Rings	http://linked.opendata.cz/resource/drugbank/property/271B5CA8-363D-11E5-9242-09173F13E4C5
http://linked.open...siological-Charge	http://linked.opendata.cz/resource/drugbank/property/271B5CA7-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Rule-of-Five	http://linked.opendata.cz/resource/drugbank/property/271B5CAA-363D-11E5-9242-09173F13E4C5
http://linked.open...tional-IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B5C99-363D-11E5-9242-09173F13E4C5
http://linked.open...-strongest-basic-	http://linked.opendata.cz/resource/drugbank/property/271B5CA6-363D-11E5-9242-09173F13E4C5

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 116 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software